A phase 2 study of vorinostat in acute myeloid leukemia

Authors

Eric W. Schaefer, Mayo Clinic Cancer Center
Arturo Loaiza-Bonilla, Harbor Hospital Center
Mark Juckett, University of Wisconsin Comprehensive Cancer Center
John F. DiPersio, Washington University School of Medicine in St. LouisFollow
Vivek Roy, Mayo Clinic
James Slack, Mayo Clinic
Wenting Wu, Mayo Clinic Cancer Center
Kristina Laumann, Mayo Clinic Cancer Center
Igor Espinoza-Delgado, National Cancer Institute
Steven D. Gore, Johns Hopkins University

Journal

Haematologica

Publication Date

2009

Volume

94

Issue

10

Inclusive Pages

1375-1382

Document Type

Open Access Publication

DOI

10.3324/haematol.2009.009217

Rights and Permissions

Eric W. Schaefer, et al. (2009) A phase 2 study of vorinostat in acute myeloid leukemia. Haematologica 94(10):1375-1382. doi:10.3324/haematol.2009.009217. Obtained from the Haematologica Journal website http://www.haematologica.org

Recommended Citation

Schaefer, Eric W.; Loaiza-Bonilla, Arturo; Juckett, Mark; DiPersio, John F.; Roy, Vivek; Slack, James; Wu, Wenting; Laumann, Kristina; Espinoza-Delgado, Igor; and Gore, Steven D., "A phase 2 study of vorinostat in acute myeloid leukemia." Haematologica. 94, 10. 1375-1382. (2009).
https://digitalcommons.wustl.edu/open_access_pubs/4225